BioInnovatise is a growing, minority-owned biotechnology company that serves research and development laboratories in the I-270 Technology Corridor and beyond. Our cloning and viral vector experts have advised and produced custom projects to further the research of numerous startups, large pharmaceutical companies, academic labs, and government agencies, including the NIH and FDA. At BioInnovatise, we specialize in custom cloning services and products, with a focus on the early stages of the drug discovery process. Researchers rely on our commitment to high-quality production with minimal turnaround time. We look forward to the opportunity to support researchers in their pursuit to make new breakthroughs in their respective fields.